Related Experiment Video

Updated: Aug 18, 2026

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
06:08

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump

Published on: March 11, 2017

A model for the determination of carbamazepine clearance in children on mono- and polytherapy

A L Gray1, J H Botha, R Miller

  • 1Department of Pharmacy, University of Durban-Westville, South Africa. agray@pixie.udw.ac.za

European Journal of Clinical Pharmacology
|August 11, 1998
PubMed

Insights

A new model predicts carbamazepine (CBZ) clearance in children based on weight, age, and other medications. This helps determine the correct CBZ maintenance dose for effective treatment.

Area of Science:

  • Pharmacokinetics
  • Pediatric Pharmacology
  • Drug Metabolism

Background:

  • Carbamazepine (CBZ) is a widely used antiepileptic drug.
  • Accurate dosing is crucial for therapeutic efficacy and minimizing toxicity in children.
  • Individual patient factors significantly influence CBZ pharmacokinetics.

Purpose of the Study:

  • To develop a pharmacokinetic model for carbamazepine (CBZ) clearance in pediatric patients.
  • To identify key patient characteristics affecting CBZ clearance.
  • To enable precise prediction of CBZ maintenance doses in children.

Main Methods:

  • Utilized 118 steady-state serum CBZ concentrations from 72 pediatric outpatients (2.3-16.3 years).
  • Employed a one-compartment model fitted using the NONMEM software.
  • Analyzed data from patients on monotherapy, valproate, or enzyme inducers (phenytoin, phenobarbitone).

Main Results:

  • CBZ clearance is significantly influenced by patient weight, age, and concomitant medications.
  • Developed clearance model: CL = [0.7(WT)^0.4] * M, where WT is weight (kg) and M accounts for medication interactions.
  • M = 1 for monotherapy/valproate, M = 1.4 for inducers; bioavailability (f) assumed complete.

Conclusions:

  • CBZ clearance decreases with increasing age in children.
  • Weight and age are satisfactory predictors of CBZ clearance due to their correlation.
  • The derived model accurately predicts CBZ clearance, aiding in individualized pediatric dosing.
Abstract

More Related Videos

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis07:16

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis

Published on: September 20, 2024

Related Concept Videos

Clearance Models: Compartment Models01:25

Clearance Models: Compartment Models

Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume of...
Clearance Models: Noncompartmental Models01:17

Clearance Models: Noncompartmental Models

Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...